These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 21809010)

  • 1. Omalizumab in the treatment of eosinophilic esophagitis and food allergy.
    Rocha R; Vitor AB; Trindade E; Lima R; Tavares M; Lopes J; Dias JA
    Eur J Pediatr; 2011 Nov; 170(11):1471-4. PubMed ID: 21809010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE.
    Clayton F; Fang JC; Gleich GJ; Lucendo AJ; Olalla JM; Vinson LA; Lowichik A; Chen X; Emerson L; Cox K; O'Gorman MA; Peterson KA
    Gastroenterology; 2014 Sep; 147(3):602-9. PubMed ID: 24907494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-IgE--emerging opportunities for Omalizumab.
    Babu KS; Polosa R; Morjaria JB
    Expert Opin Biol Ther; 2013 May; 13(5):765-77. PubMed ID: 23517576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of omalizumab in the treatment of food allergy and anaphylaxis.
    Lieberman JA; Chehade M
    Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of omalizumab in patients with food allergy.
    Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
    Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of quality of life in patients with concomitant allergic asthma and atopic dermatitis: one year follow-up of omalizumab therapy.
    Velling P; Skowasch D; Pabst S; Jansen E; Tuleta I; Grohé C
    Eur J Med Res; 2011 Sep; 16(9):407-10. PubMed ID: 22024441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omalizumab in children with severe allergic disease: a case series.
    Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
    Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omalizumab for the Treatment of Multiple Food Allergies.
    Hui Shi En E; Cheng-Chung Wei J
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810197
    [No Abstract]   [Full Text] [Related]  

  • 9. [A case of severe asthma and peach allergy that improved with omalizumab therapy: a case report].
    Suzuki S; Matsuura T; Kimura T; Tazaki T; Fukuda M; Homma T; Matsukura S; Kurokawa M; Adachi M
    Arerugi; 2012 Feb; 61(2):215-23. PubMed ID: 22437731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis.
    Arasi S; Costa S; Magazzù G; Ieni A; Crisafulli G; Caminiti L; Chiera F; Vaccaro M; Del Giudice MM; Pajno GB
    Ital J Pediatr; 2016 Mar; 42():32. PubMed ID: 27000314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases.
    D'Amato G; Liccardi G; Noschese P; Salzillo A; D'Amato M; Cazzola M
    Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):227-9. PubMed ID: 15379589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omalizumab for the Treatment of Multiple Food Allergies. Reply.
    Wood RA; Togias A; Chinthrajah RS
    N Engl J Med; 2024 May; 390(20):1936. PubMed ID: 38810198
    [No Abstract]   [Full Text] [Related]  

  • 13. Anti-IgE therapy: clinical utility beyond asthma.
    Casale TB; Stokes J
    J Allergy Clin Immunol; 2009 Apr; 123(4):770-1.e1. PubMed ID: 19348915
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-IgE therapy and severe atopic dermatitis: a pediatric perspective.
    Lacombe Barrios J; Bégin P; Paradis L; Hatami A; Paradis J; Des Roches A
    J Am Acad Dermatol; 2013 Nov; 69(5):832-834. PubMed ID: 24124824
    [No Abstract]   [Full Text] [Related]  

  • 15. Omalizumab : other indications and unanswered questions.
    Mankad VS; Burks AW
    Clin Rev Allergy Immunol; 2005 Aug; 29(1):17-30. PubMed ID: 16222081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab treatment in severe adult atopic dermatitis.
    Thaiwat S; Sangasapaviliya A
    Asian Pac J Allergy Immunol; 2011 Dec; 29(4):357-60. PubMed ID: 22299316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Food allergy and eosinophilic esophagitis: what do we do?
    Chehade M; Aceves SS; Furuta GT; Fleischer DM
    J Allergy Clin Immunol Pract; 2015; 3(1):25-32. PubMed ID: 25577614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma.
    Gevaert P; Calus L; Van Zele T; Blomme K; De Ruyck N; Bauters W; Hellings P; Brusselle G; De Bacquer D; van Cauwenberge P; Bachert C
    J Allergy Clin Immunol; 2013 Jan; 131(1):110-6.e1. PubMed ID: 23021878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
    Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
    Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab, an anti-immunoglobulin E antibody: state of the art.
    Incorvaia C; Mauro M; Russello M; Formigoni C; Riario-Sforza GG; Ridolo E
    Drug Des Devel Ther; 2014; 8():197-207. PubMed ID: 24532966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.